6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
Just now	Quarterly Activities Report - March 2026
Just now	Appendix 4C and Quarterly Activities Report - March 2026
6m ago	Diagens Annual Results: 100B-Parameter Model Reshapes Medical AI Landscape; Licensing Revenue Becomes Primary Growth Engine
6m ago	ING completes share buyback and announces new programme of up to €1.0 billion
6m ago	argenx to Report First Quarter 2026 Financial Results and Business Update on May 7, 2026

About

Kuros Biosciences Ag (SW:KURN) — investor relations, events, news, and company updates on 6ix.

Latest News

Kuros Biosciences reports 51% year-over-year increase in sales in the first three months of 2026

Kuros Biosciences delivers 72% year-over-year sales growth, reaching USD 146.1 million for 2025

Kuros Biosciences to provide investor update at Octavian and Baader Bank Conferences

Kuros Biosciences announces enrollment of first patient in ASTRA study – A global, prospective, randomized, multi-center clinical trial in foot and ankle fusion

Kuros Biosciences to present at the Piper Sandler 37th Annual Healthcare Conference

Financials

Revenue

CHF146.06 M

Market Cap

CHF898.77 M

P/E Ratio

382.33

EPS

0.06

Community Chat

Ask AI